Suchergebnisse - "Brunetti, Oronzo"

PubPharm (13)

1

Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2023

von Simbolo, M. | Silvestris, N. | Malleo, G. | +29

2

Impact of COVID-19 pandemic on outpatient visit volume in cancer patients : Results of COMETA multicenter retrospective observational study

enthalten in: Frontiers in public health | 2023

von Frisardi, V. | Brunetti, O. | Abbinante, V. | +15

3

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro

enthalten in: Frontiers in immunology | 2022

von Ghorbaninezhad, F. | Masoumi, J. | Bakhshivand, M. | +10

4

PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma : a pilot study

enthalten in: Expert opinion on therapeutic targets | 2021

von Silvestris, N. | Argentiero, A. | Brunetti, O. | +11

5

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer : Toward Single-Cell Sequencing-Guided Biomimetic Delivery

enthalten in: Genes | 2021

von Shadbad, M. | Safaei, S. | Brunetti, O. | +9

6

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy : Lessons Learned and the Road Ahead

enthalten in: Frontiers in immunology | 2021

von Hosseinkhani, N. | Derakhshani, A. | Shadbad, M. | +7

7

Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells

enthalten in: BMC cancer | 2015

von Simone, V. | Ciavarella, S. | Brunetti, O. | +6

8

MicroRNA in pancreatic adenocarcinoma : predictive/prognostic biomarkers or therapeutic targets?

enthalten in: Oncotarget | 2015

von Brunetti, O. | Russo, A. | Scarpa, A. | +12

9

Bone metastases in hepatocellular carcinoma : an emerging issue

enthalten in: Cancer metastasis reviews | 2014

von Longo, V. | Brunetti, O. | D'Oronzo, S. | +3

10

Novel lenalidomide-based combinations for treatment of multiple myeloma

enthalten in: Critical reviews in oncology/hematology | 2013

von Cives, M. | Simone, V. | Brunetti, O. | +2